These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16896187)

  • 1. Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production.
    Lock HR; Sacks SH; Robson MG
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F76-81. PubMed ID: 16896187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
    Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
    Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell lines.
    Heuer M; Benkö T; Cicinnati VR; Kaiser GM; Sotiropoulos GC; Baba HA; Treckmann JW; Broelsch CE; Paul A
    Transplant Proc; 2009; 41(1):359-65. PubMed ID: 19249557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
    Giannico G; Cortes P; Baccora MH; Hassett C; Taube DW; Yee J
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F57-65. PubMed ID: 16896180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
    Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
    Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
    Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
    Grozinsky-Glasberg S; Rubinfeld H; Nordenberg Y; Gorshtein A; Praiss M; Kendler E; Feinmesser R; Grossman AB; Shimon I
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):87-94. PubMed ID: 19815051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine induces phosphorylation and activation of p70S6K in cortical neurons via the system L amino acid transporter.
    Ishizuka Y; Kakiya N; Nawa H; Takei N
    J Neurochem; 2008 Jul; 106(2):934-42. PubMed ID: 18435829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinoma.
    Baba HA; Wohlschlaeger J; Cicinnati VR; Hilgard P; Lang H; Sotiropoulos GC; Takeda A; Beckebaum S; Schmitz KJ
    Liver Int; 2009 Mar; 29(3):399-405. PubMed ID: 18492014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer.
    Nozawa H; Watanabe T; Nagawa H
    Cancer Lett; 2007 Jun; 251(1):105-13. PubMed ID: 17175097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro.
    Zhang JF; Liu JJ; Lu MQ; Cai CJ; Yang Y; Li H; Xu C; Chen GH
    Transpl Immunol; 2007 Apr; 17(3):162-8. PubMed ID: 17331842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53.
    Rosner D; McCarthy N; Bennett M
    Cardiovasc Res; 2005 Jun; 66(3):601-10. PubMed ID: 15914125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
    Tirado OM; Mateo-Lozano S; Notario V
    Oncogene; 2005 May; 24(20):3348-57. PubMed ID: 15782132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of osteopontin upregulation on mesangial cells growth and collagen synthesis induced by intermittent high glucose.
    Sun J; Xu Y; Deng H; Sun S; Dai Z; Sun Y
    J Cell Biochem; 2010 Apr; 109(6):1210-21. PubMed ID: 20135641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition.
    Ha H; Kim MS; Park J; Huh JY; Huh KH; Ahn HJ; Kim YS
    Life Sci; 2006 Sep; 79(16):1561-7. PubMed ID: 16740277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.